Articles

Many patients diagnosed with skin cancer do not know whether they have melanoma or nonmelanoma skin cancer and, as a result, may have a poor sense of the measures they need to take to reduce the risk of future skin cancers, a study by an investigator at the Cancer Institute of New Jersey, New Brunswick, indicates.
 
Read More ›

In a long-term study of men who underwent robot-assisted radical prostatectomy (RARP) nearly 87% had no recurrence of the disease after 5 years.
 
The study cohort included 1384 men who were diagnosed with moderately aggressive localized prostate cancer and underwent RARP between September 2001 and May 2005 at a tertiary center. Their average age was 60 years.
 
Read More ›

Researchers identified an association between type 2 diabetes and colorectal cancer (CRC) among men. The association did not hold for women. The new study, published in the October issue of Gastroenterology, found that the risk existed regardless of insulin use. Insulin use, in fact, was found to be associated with a slight but not substantially increased risk of CRC.
 
Read More ›

Use of hospice care for men with prostate cancer has increased significantly over the past 2 decades, but most wait too long to enroll, when they cannot take full advantage of the palliative care services offered, researchers at UCLA's Jonsson Comprehensive Cancer Center have found.

Read More ›

Cancer patients with pain or depression often also have physical symptoms, such as fatigue, dry mouth and nausea, that can cause disability, a new study shows.
 
“This study strengthens the case for improving the recognition and treatment of somatic symptoms in patients with cancer,” the researchers said in a news release.
 
Read More ›

Many patients with advanced cancers and a poor prognosis receive routine screenings—mammograms, Pap smears, prostate-specific antigen (PSA) tests—for other cancers even though there is little likelihood of these tests to provide benefit, according to a new study released in the October issue of JAMA.
 
Read More ›

Patients with advanced non–small-cell lung cancer (NSCLC) achieved a significant increase in overall survival when tumor treating fields (TTF) therapy was added to pemetrexed every 3 weeks, according to data released by Novocure at the European Society for Medical Oncology Congress.
 
Read More ›

Cancer survivorship can mean different things to different survivors. The consequences of cancer and its treatments can affect individuals in many ways. Read More ›


recent editorial in the Annals of Internal Medicine states, “If survivorship is a priority, we can improve the lives of survivors.”1 Increasing recognition of the importance of making survivorship care a priority was the motivating factor for this issue dedicated to cancer survivorship.

Read More ›

Difficulties with intimacy and sexuality are among the most common and longest lasting side effects of cancer treatments and can be caused by any of the cancer treatments currently available.1 Fortunately, even simple recommendations can go a long way toward ameliorating distress for most patients and their partners.2,3 Yet until recently this aspect of care for cancer patients has remained one o Read More ›


Page 362 of 376


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: